Abida Khan
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Tuberculosis Research and Epidemiology
- Virology top 10%
- Poxvirus research and outbreaks
Papers in
-
- Cancer therapeutics and mechanisms 3
-
- Synthesis and biological activity 7
- Click Chemistry and Applications 3
- Synthesis and Characterization of Heterocyclic Compounds 2
- Co-authors
- Mohd Imran (29 shared papers)Hamdy Khamees Thabet (7 shared papers)Ahmed Subeh Alshrari (7 shared papers)Saleh I. Alaqel (8 shared papers)Mohammed Kanan Alshammari (7 shared papers)Syed Mohammed Basheeruddin Asdaq (10 shared papers)Shah Alam Khan (4 shared papers)Md. Afroz Bakht (4 shared papers)
- Journals
- Molecules (4 papers)Biogerontology (3 papers)Expert Opinion on Therapeutic Patents (3 papers)Cancers (3 papers)Journal of Infection and Public Health (2 papers)
- Partner nations
- Saudi ArabiaIndiaPakistan
In The Last Decade
Abida Khan
43 papers receiving 645 citations
Peers
Comparison fields: 5 of 104
- Infectious Diseases 153
- Virology 37
- Complementary and alternative medicine 46
- Pharmacology 36
- Geriatrics and Gerontology 13
Countries citing papers authored by Abida Khan
This map shows the geographic impact of Abida Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abida Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abida Khan more than expected).
Fields of papers citing papers by Abida Khan
This network shows the impact of papers produced by Abida Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abida Khan. The network helps show where Abida Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Abida Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2022 | 52 | |
| 3 | 2021 | 38 | |
| 4 | 2021 | 30 | |
| 5 | 2013 | 25 | |
| 6 | 2024 | 25 | |
| 7 | 2017 | 25 | |
| 8 | 2020 | 24 | |
| 9 | 2023 | 23 | |
| 10 | 2023 | 22 | |
| 11 | 2024 | 22 | |
| 12 | 2022 | 21 | |
| 13 | 2023 | 20 | |
| 14 | 1999 | 19 | |
| 15 | 2021 | 17 | |
| 16 | An Updated Review: Newer Quinazoline Derivatives Under Clinical Trial | 2011 | 17 |
| 17 | 2023 | 17 | |
| 18 | 2024 | 17 | |
| 19 | 2022 | 15 | |
| 20 | 2020 | 12 |
About Abida Khan
Abida Khan is a scholar working on Molecular Biology, Organic Chemistry, Infectious Diseases, Pharmacology and Epidemiology, having authored 50 papers that have together received 664 indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Computational Drug Discovery Methods (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Helminth infection and control (3 papers), Click Chemistry and Applications (3 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer therapeutics and mechanisms (3 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Infectious Diseases (153 citations), Virology (37 citations), Complementary and alternative medicine (46 citations), Pharmacology (36 citations) and Geriatrics and Gerontology (13 citations). Abida Khan has collaborated with scholars based in Saudi Arabia, India and Pakistan. Frequent co-authors include Mohd Imran, Hamdy Khamees Thabet, Ahmed Subeh Alshrari, Saleh I. Alaqel, Mohammed Kanan Alshammari, Syed Mohammed Basheeruddin Asdaq, Shah Alam Khan, Md. Afroz Bakht, Mehnaz Kamal and Mandeep Kumar Arora. Their work appears in journals such as Molecules, Biogerontology, Expert Opinion on Therapeutic Patents, Cancers and Journal of Infection and Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.